Arval — Puractiva Bio-matifyng system
Body cream, advertised as mattifying, 50 ml.
- Risk level
- Serious risk
- Type
- Chemical
- Category
- Cosmetics
- Hazard
- According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA) and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), which are prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. HICC may cause an allergic skin reaction.
- Origin
- Switzerland
⚖️ Actions ordered by authorities
- ▸ (to: Distributor) Ban on the marketing of the product and any accompanying measures
8025935270047
What is this? This is a skin-care product called Puractiva Bio-matifying system made by Arval. It is sold as a cosmetic.
What's happening? Tests show the product has two banned chemicals: BMHCA and HICC. These can hurt unborn babies, harm the reproductive system, or cause skin allergies.
Does this affect me? If you used this product in Italy, you may be at risk.
What should I do? Stop using it now. Ask your pharmacist or doctor if you have any health concerns.
🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.
🔬 Medical / technical details (for professionals)
Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA) and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), which are prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. HICC may cause an allergic skin reaction. · Origin: Switzerland
All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.